• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺髓质素/叉头框蛋白 O3 通过抑制 FDX1 表达和铜死亡增强肾透明细胞癌对舒尼替尼的耐药性。

Adrenomedullin/FOXO3 enhances sunitinib resistance in clear cell renal cell carcinoma by inhibiting FDX1 expression and cuproptosis.

机构信息

Department of Urology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.

出版信息

FASEB J. 2023 Oct;37(10):e23143. doi: 10.1096/fj.202300474R.

DOI:10.1096/fj.202300474R
PMID:37698353
Abstract

Cuproptosis, a new type of copper-induced cell death, is involved in the antitumor activity and resistance of multiple chemotherapeutic drugs. Our previous study revealed that adrenomedullin (ADM) was engaged in sunitinib resistance in clear cell renal cell carcinoma (ccRCC). However, it has yet to be investigated whether and how ADM regulates sunitinib resistance by cuproptosis. This study found that the ADM expression was elevated in sunitinib-resistant ccRCC tissues and cells. Furthermore, the upregulation of ADM significantly enhanced the chemoresistance of sunitinib compared with their respective control. Moreover, cuproptosis was involved in ADM-regulated sunitinib resistance by inhibiting mammalian ferredoxin 1 (FDX1) expression. Mechanically, the upregulated ADM activates the p38/MAPK signaling pathway to promote Forkhead box O3 (FOXO3) phosphorylation and its entry into the nucleus. Consequently, the increased FOXO3 in the nucleus inhibited FDX1 transcription and cell cuproptosis, promoting chemoresistance. Collectively, cuproptosis has a critical effector role in ccRCC progress and chemoresistance and thus is a relevant target to eradicate the cell population of sunitinib resistance.

摘要

铜死亡是一种新型的铜诱导细胞死亡方式,参与多种化疗药物的抗肿瘤活性和耐药性。我们之前的研究表明,肾上腺髓质素(ADM)参与了肾透明细胞癌(ccRCC)中舒尼替尼的耐药性。然而,ADM 是否以及如何通过铜死亡调节舒尼替尼耐药性仍有待研究。本研究发现 ADM 在舒尼替尼耐药性 ccRCC 组织和细胞中表达上调。此外,与各自对照相比,ADM 的上调显著增强了舒尼替尼的化学耐药性。此外,铜死亡通过抑制哺乳动物铁氧还蛋白 1(FDX1)表达参与 ADM 调节的舒尼替尼耐药性。机制上,上调的 ADM 激活 p38/MAPK 信号通路,促进叉头框 O3(FOXO3)磷酸化及其进入细胞核。因此,核内增加的 FOXO3 抑制了 FDX1 转录和细胞铜死亡,促进了化学耐药性。总之,铜死亡在 ccRCC 的进展和化学耐药性中起着关键的效应子作用,因此是消除舒尼替尼耐药细胞群的相关靶点。

相似文献

1
Adrenomedullin/FOXO3 enhances sunitinib resistance in clear cell renal cell carcinoma by inhibiting FDX1 expression and cuproptosis.肾上腺髓质素/叉头框蛋白 O3 通过抑制 FDX1 表达和铜死亡增强肾透明细胞癌对舒尼替尼的耐药性。
FASEB J. 2023 Oct;37(10):e23143. doi: 10.1096/fj.202300474R.
2
Multi-omics pan-cancer study of cuproptosis core gene and its role in kidney renal clear cell carcinoma.泛癌多组学研究铜死亡核心基因及其在肾透明细胞癌中的作用。
Front Immunol. 2022 Dec 20;13:981764. doi: 10.3389/fimmu.2022.981764. eCollection 2022.
3
Cuproptosis-Related MiR-21-5p/FDX1 Axis in Clear Cell Renal Cell Carcinoma and Its Potential Impact on Tumor Microenvironment.铜死亡相关 miR-21-5p/FDX1 轴在肾透明细胞癌中的作用及其对肿瘤微环境的潜在影响。
Cells. 2022 Dec 31;12(1):173. doi: 10.3390/cells12010173.
4
Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma.新型铜死亡相关二氢硫辛酰胺支链转酰基酶 E2(DBT)标志物在舒尼替尼耐药肾透明细胞癌中的潜在机制。
Aging (Albany NY). 2024 Feb 1;16(3):2679-2701. doi: 10.18632/aging.205504.
5
The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma.铜死亡相关的 13 基因特征作为透明细胞肾细胞癌患者预后和免疫及靶向治疗反应的有力预测指标。
Front Immunol. 2022 Sep 5;13:971142. doi: 10.3389/fimmu.2022.971142. eCollection 2022.
6
A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma.一个新的铜死亡相关预后基因特征,并在透明细胞肾细胞癌中验证差异表达。
Genes (Basel). 2022 May 10;13(5):851. doi: 10.3390/genes13050851.
7
Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.铜死亡状态影响肾透明细胞癌患者免疫治疗和靶向治疗的治疗选择。
Front Immunol. 2022 Aug 19;13:954440. doi: 10.3389/fimmu.2022.954440. eCollection 2022.
8
Confirmation of the predictive function of cuproptosis-related gene FDX1 in clear cell renal carcinoma using qRT-PCR and western blotting.使用 qRT-PCR 和 western blot 验证铜死亡相关基因 FDX1 在透明细胞肾细胞癌中的预测功能。
Aging (Albany NY). 2023 Jul 10;15(13):6117-6134. doi: 10.18632/aging.204807.
9
Cuproptosis identifies respiratory subtype of renal cancer that confers favorable prognosis.铜死亡鉴定出具有良好预后的肾癌呼吸亚型。
Apoptosis. 2022 Dec;27(11-12):1004-1014. doi: 10.1007/s10495-022-01769-2. Epub 2022 Sep 14.
10
Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma.生物信息学分析和实验验证在透明细胞肾细胞癌中铜死亡相关 lncRNA LINC02154 的作用。
BMC Cancer. 2023 Feb 16;23(1):160. doi: 10.1186/s12885-023-10639-2.

引用本文的文献

1
Copper metabolism and cuproptosis: broad perspectives in the treatment of hepatocellular carcinoma.铜代谢与铜死亡:肝细胞癌治疗的广阔前景
Front Oncol. 2025 Jul 30;15:1555858. doi: 10.3389/fonc.2025.1555858. eCollection 2025.
2
Unraveling the role of GPCR signaling in metabolic reprogramming and immune microenvironment of lung adenocarcinoma: a multi-omics study with experimental validation.揭示GPCR信号在肺腺癌代谢重编程和免疫微环境中的作用:一项具有实验验证的多组学研究
Front Immunol. 2025 Jun 6;16:1606125. doi: 10.3389/fimmu.2025.1606125. eCollection 2025.
3
Chronic systemic inflammation by peptidoglycan-polysaccharide induces skeletal muscle atrophy in male and ovariectomized C57BL/6J mice.
肽聚糖-多糖引起的慢性全身炎症会导致雄性和去卵巢C57BL/6J小鼠骨骼肌萎缩。
Physiol Rep. 2025 Jun;13(12):e70431. doi: 10.14814/phy2.70431.
4
Cuproptosis-related genes and agents: implications in tumor drug resistance and future perspectives.铜死亡相关基因与药物:对肿瘤耐药性的影响及未来展望
Front Pharmacol. 2025 May 8;16:1559236. doi: 10.3389/fphar.2025.1559236. eCollection 2025.
5
Copper-mediated SEC14L3 promotes cuproptosis to inhibit hepatocellular carcinoma growth via ERK/YY1/FDX1 axis.铜介导的SEC14L3通过ERK/YY1/FDX1轴促进铜死亡以抑制肝细胞癌生长。
Commun Biol. 2025 Apr 24;8(1):658. doi: 10.1038/s42003-025-08101-z.
6
FDX1 overexpression inhibits the growth and metastasis of clear cell renal cell carcinoma by upregulating FMR1 expression.FDX1过表达通过上调FMR1表达来抑制透明细胞肾细胞癌的生长和转移。
Cell Death Discov. 2025 Mar 21;11(1):115. doi: 10.1038/s41420-025-02380-5.
7
Adrenomedullin Inhibits the Efficacy of Combined Immunotherapy and Targeted Therapy in Biliary Tract Cancer by Disrupting Endothelial Cell Functions.肾上腺髓质素通过破坏内皮细胞功能抑制胆道癌联合免疫治疗和靶向治疗的疗效。
J Cell Mol Med. 2025 Mar;29(5):e70460. doi: 10.1111/jcmm.70460.
8
AKT1 Phosphorylates FDX1 to Promote Cuproptosis Resistance in Triple-Negative Breast Cancer.AKT1磷酸化FDX1以促进三阴性乳腺癌中的铜死亡抗性。
Adv Sci (Weinh). 2025 May;12(17):e2408106. doi: 10.1002/advs.202408106. Epub 2025 Feb 20.
9
Copper homeostasis and copper-induced cell death in tumor immunity: implications for therapeutic strategies in cancer immunotherapy.铜稳态与肿瘤免疫中的铜诱导细胞死亡:对癌症免疫治疗策略的启示
Biomark Res. 2024 Oct 31;12(1):130. doi: 10.1186/s40364-024-00677-8.
10
The Role of Adrenomedullin as a Predictive Marker of the Risk of Death and Adverse Clinical Events: A Review of the Literature.肾上腺髓质素作为死亡风险和不良临床事件预测标志物的作用:文献综述
J Clin Med. 2024 Aug 16;13(16):4847. doi: 10.3390/jcm13164847.